company_name,company_legal_names,company_commercial_names,main_country_code,main_region,main_city_district,main_city,main_postcode,main_street,main_street_number,main_latitude,main_longitude,main_address_raw_text,locations,short_description,long_description,business_tags,product_type,main_industry,main_sector,primary_phone,phone_numbers,primary_email,emails,other_emails,website_url,website_domain,website_language_code,facebook_url,twitter_url,instagram_url,linkedin_url,ios_app_url,android_app_url,youtube_url,generated_description,generated_business_tags,domains,id
cel-sci's,cel-sci corporation,cel-sci's,us,virginia,,fairfax county,22182,boone boulevard,8229,38.91540535,-77.23110210956096,"8229 boone boulevard, suite 802 vienna, va 22182 usa","us, united states, virginia, fairfax county, 22182, boone boulevard, 8229, 38.91540535, -77.23110210956096","cel-sci's is a biotechnology company based in fairfax county, virginia, united states.","dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases. cel-sci is a pioneer in cancer immunotherapy. that's the root of cel-sci's mission. we strive to create real value for our stakeholders by developing innovative therapies that have the potential to address unmet medical needs. cel-sci's vision is to change the way cancer is treated. cel-sci corporation (nyse american: cvm), a biotechnology company, is involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases. cel-sci's idea and aim is to help cancer patients by boosting their immune system before the ravages of surgery, radiation and chemotherapy. we believe that boosting a cancer patient's immune system while it is still intact, should provide the greatest possible impact on survival. cel-sci also has an early development technology leaps for the treatment of rheumatoid arthritis, other autoimmune and infectious diseases.",trial design | drug discovery | mechanisms of action | product pipeline | head and neck cancer | cancer immunotherapy | research & development | phase iii | experimental drugs | squamous cell carcinoma | patient enrollment | clinical oncology | drug development | clinical research | regulatory submission | biotechnology | animal studies | orphan drugs | drug production | regulatory affairs | infectious diseases | oncology | cancer patients | rheumatoid arthritis | litigation funding | patent attorneys | small engine | consulting firm | nccn guidelines | marketplace | trial results | pilot plants | commercial developments | real estate investments | shareholder letters | sec filings | posters and presentations,professional services,research & development services,other professional services,+17035069460,+17035069460,feedback@cel-sci.com,feedback@cel-sci.com,,,cel-sci.com,en,celscicorp/,CelSciCorp,,company/cel-sci-corporation,,,,"cel-sci's, legally known as cel-sci corporation, based in vienna, virginia, is a biotechnology company founded in 1983. the company specializes in the research and development of immunotherapy products aimed at treating cancer, autoimmune, and infectious diseases. cel-sci's core capabilities encompass drug discovery, research, development, and manufacturing of complex biological substances. the company's lead investigational therapy, multikineÂ®, is being developed as a potential therapeutic agent to enhance the immune system's anti-tumor response. cel-sci is committed to improving cancer treatment by leveraging the body's natural immune defense system.",biotechnology research and development | therapeutic agents development | therapies for infectious diseases | leukocyte interleukin injection | systemic antitumor response activation,multikin.com | cel-sci.org | cel-sci.com | cel-sci.net | multikin.org,18160
